{"transactions":[{"id":4618713,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2026-09-15T23:18:39.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The warrant vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":164992,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000098","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000090765426000098/form4.xml","form_type":"4"}},{"id":4618712,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-09-15T23:18:39.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":193563,"derivative":{"exercise_price":6.84,"expiration_date":"2034-05-06","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000098","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000090765426000098/form4.xml","form_type":"4"}},{"id":4618711,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-15T23:18:39.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":947,"price":95.71,"value":90637.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"These sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units."}],"balance_after":31771,"source":{"system":"sec-edgar","filing":"0000907654-26-000098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000090765426000098/form4.xml","form_type":"4"}},{"id":4618710,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-15T23:18:39.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":100,"price":94.2172,"value":9421.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.04 to $94.35, inclusive."}],"balance_after":32718,"source":{"system":"sec-edgar","filing":"0000907654-26-000098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000090765426000098/form4.xml","form_type":"4"}},{"id":4618709,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-15T23:18:39.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":1366,"price":92.9888,"value":127022.7008,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.62 to $93.54, inclusive."}],"balance_after":32818,"source":{"system":"sec-edgar","filing":"0000907654-26-000098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000090765426000098/form4.xml","form_type":"4"}},{"id":4618708,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-15T23:18:39.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":3150,"price":92.0285,"value":289889.775,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.56 to $92.55, inclusive."}],"balance_after":34184,"source":{"system":"sec-edgar","filing":"0000907654-26-000098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000090765426000098/form4.xml","form_type":"4"}},{"id":4618707,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-15T23:18:39.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":2384,"price":91.0962,"value":217173.3408,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.52 to $91.51, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4."}],"balance_after":37334,"source":{"system":"sec-edgar","filing":"0000907654-26-000098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000090765426000098/form4.xml","form_type":"4"}},{"id":4618706,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-15T23:18:39.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":39718,"source":{"system":"sec-edgar","filing":"0000907654-26-000098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000090765426000098/form4.xml","form_type":"4"}},{"id":4618705,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-15T23:18:39.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":6.84,"value":23940.0,"ownership":{"direct":true},"balance_after":36218,"source":{"system":"sec-edgar","filing":"0000907654-26-000098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000090765426000098/form4.xml","form_type":"4"}},{"id":686116,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2026-08-17T22:09:40.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The warrant vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":168492,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000079","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000079/form4.xml","form_type":"4"}},{"id":686115,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-08-17T22:09:40.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":197063,"derivative":{"exercise_price":6.84,"expiration_date":"2034-05-06","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000079","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000079/form4.xml","form_type":"4"}},{"id":686114,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-17T22:09:40.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":2480,"price":112.5622,"value":279154.256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.34 to $112.86, inclusive."}],"balance_after":32718,"source":{"system":"sec-edgar","filing":"0000907654-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000079/form4.xml","form_type":"4"}},{"id":686113,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-17T22:09:40.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":3320,"price":112.0138,"value":371885.816,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.34 to $112.33, inclusive."}],"balance_after":35198,"source":{"system":"sec-edgar","filing":"0000907654-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000079/form4.xml","form_type":"4"}},{"id":686112,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-17T22:09:40.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":300,"price":110.5167,"value":33155.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.27 to $111.00, inclusive."}],"balance_after":38518,"source":{"system":"sec-edgar","filing":"0000907654-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000079/form4.xml","form_type":"4"}},{"id":686111,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-17T22:09:40.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":900,"price":109.6522,"value":98686.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.05 to $110.04, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4."}],"balance_after":38818,"source":{"system":"sec-edgar","filing":"0000907654-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000079/form4.xml","form_type":"4"}},{"id":686110,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-17T22:09:40.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":39718,"source":{"system":"sec-edgar","filing":"0000907654-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000079/form4.xml","form_type":"4"}},{"id":686109,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-17T22:09:40.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":6.84,"value":23940.0,"ownership":{"direct":true},"balance_after":36218,"source":{"system":"sec-edgar","filing":"0000907654-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000079/form4.xml","form_type":"4"}},{"id":709315,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2026-07-15T23:36:35.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The warrant vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":171992,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000073/form4.xml","form_type":"4"}},{"id":709314,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-15T23:36:35.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":200563,"derivative":{"exercise_price":6.84,"expiration_date":"2034-05-06","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000073/form4.xml","form_type":"4"}},{"id":709313,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-15T23:36:35.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":300,"price":87.2533,"value":26175.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.25 to $87.26, inclusive."}],"balance_after":32718,"source":{"system":"sec-edgar","filing":"0000907654-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000073/form4.xml","form_type":"4"}},{"id":709312,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-15T23:36:35.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":3803,"price":86.6764,"value":329630.3492,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.21 to $87.04, inclusive."}],"balance_after":33018,"source":{"system":"sec-edgar","filing":"0000907654-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000073/form4.xml","form_type":"4"}},{"id":709311,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-15T23:36:35.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":2497,"price":85.8572,"value":214385.4284,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.21 to $86.20, inclusive."}],"balance_after":36821,"source":{"system":"sec-edgar","filing":"0000907654-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000073/form4.xml","form_type":"4"}},{"id":709310,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-15T23:36:35.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":400,"price":84.365,"value":33746.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.87 to $84.57, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4."}],"balance_after":39318,"source":{"system":"sec-edgar","filing":"0000907654-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000073/form4.xml","form_type":"4"}},{"id":709309,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-15T23:36:35.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":39718,"source":{"system":"sec-edgar","filing":"0000907654-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000073/form4.xml","form_type":"4"}},{"id":709308,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-15T23:36:35.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":6.84,"value":23940.0,"ownership":{"direct":true},"balance_after":36218,"source":{"system":"sec-edgar","filing":"0000907654-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000073/form4.xml","form_type":"4"}},{"id":738566,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2026-06-15T22:54:31.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The warrant vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":175492,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000063/form4.xml","form_type":"4"}},{"id":738565,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-06-15T22:54:31.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":204063,"derivative":{"exercise_price":6.84,"expiration_date":"2034-05-06","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000063/form4.xml","form_type":"4"}},{"id":738564,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-15T22:54:31.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":947,"price":69.69,"value":65996.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"These sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units."}],"balance_after":32718,"source":{"system":"sec-edgar","filing":"0000907654-26-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000063/form4.xml","form_type":"4"}},{"id":738563,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-15T22:54:31.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":300,"price":70.6233,"value":21186.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.29 to $70.79, inclusive."}],"balance_after":33665,"source":{"system":"sec-edgar","filing":"0000907654-26-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000063/form4.xml","form_type":"4"}},{"id":738562,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-15T22:54:31.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":5064,"price":69.4209,"value":351547.4376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.98 to $69.83, inclusive."}],"balance_after":33965,"source":{"system":"sec-edgar","filing":"0000907654-26-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000063/form4.xml","form_type":"4"}},{"id":738561,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-15T22:54:31.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":1636,"price":68.3839,"value":111876.0604,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.97 to $68.96, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4."}],"balance_after":39029,"source":{"system":"sec-edgar","filing":"0000907654-26-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000063/form4.xml","form_type":"4"}},{"id":738560,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-15T22:54:31.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":40665,"source":{"system":"sec-edgar","filing":"0000907654-26-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000063/form4.xml","form_type":"4"}},{"id":738559,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-15T22:54:31.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":6.84,"value":23940.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 288 shares acquired under the Oruka Therapeutics, Inc. stock purchase plan on June 8, 2026."}],"balance_after":37165,"source":{"system":"sec-edgar","filing":"0000907654-26-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000063/form4.xml","form_type":"4"}},{"id":777862,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2026-05-16T00:17:32.000Z","date":"2026-05-15","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The warrant vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":178992,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000039/form4.xml","form_type":"4"}},{"id":777861,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-05-16T00:17:32.000Z","date":"2026-05-15","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":207563,"derivative":{"exercise_price":6.84,"expiration_date":"2034-05-06","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000039/form4.xml","form_type":"4"}},{"id":777860,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-16T00:17:32.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":100,"price":63.52,"value":6352.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."}],"balance_after":33377,"source":{"system":"sec-edgar","filing":"0000907654-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000039/form4.xml","form_type":"4"}},{"id":777859,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-16T00:17:32.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":2100,"price":62.423,"value":131088.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.02 to $62.89, inclusive."}],"balance_after":33477,"source":{"system":"sec-edgar","filing":"0000907654-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000039/form4.xml","form_type":"4"}},{"id":777858,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-16T00:17:32.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":4800,"price":61.5614,"value":295494.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.93 to $61.90, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":35577,"source":{"system":"sec-edgar","filing":"0000907654-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000039/form4.xml","form_type":"4"}},{"id":777857,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-16T00:17:32.000Z","date":"2026-05-15","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":40377,"source":{"system":"sec-edgar","filing":"0000907654-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000039/form4.xml","form_type":"4"}},{"id":777856,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-16T00:17:32.000Z","date":"2026-05-15","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":6.84,"value":23940.0,"ownership":{"direct":true},"balance_after":36877,"source":{"system":"sec-edgar","filing":"0000907654-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000039/form4.xml","form_type":"4"}},{"id":808427,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2026-04-15T22:45:45.000Z","date":"2026-04-15","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The warrant vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":182492,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000035/form4.xml","form_type":"4"}},{"id":808426,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-04-15T22:45:45.000Z","date":"2026-04-15","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":211063,"derivative":{"exercise_price":6.84,"expiration_date":"2034-05-06","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000035/form4.xml","form_type":"4"}},{"id":808425,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-15T22:45:45.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":500,"price":67.384,"value":33692.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.35 to $67.41, inclusive."}],"balance_after":33377,"source":{"system":"sec-edgar","filing":"0000907654-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000035/form4.xml","form_type":"4"}},{"id":808424,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-15T22:45:45.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":2273,"price":66.5643,"value":151300.6539,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.31 to $67.15, inclusive."}],"balance_after":33877,"source":{"system":"sec-edgar","filing":"0000907654-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000035/form4.xml","form_type":"4"}},{"id":808423,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-15T22:45:45.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":4227,"price":65.7291,"value":277836.9057,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.31 to $66.29, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":36150,"source":{"system":"sec-edgar","filing":"0000907654-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000035/form4.xml","form_type":"4"}},{"id":808422,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-15T22:45:45.000Z","date":"2026-04-15","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":40377,"source":{"system":"sec-edgar","filing":"0000907654-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000035/form4.xml","form_type":"4"}},{"id":808421,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-15T22:45:45.000Z","date":"2026-04-15","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":6.84,"value":23940.0,"ownership":{"direct":true},"balance_after":36877,"source":{"system":"sec-edgar","filing":"0000907654-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000035/form4.xml","form_type":"4"}},{"id":839731,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2026-03-17T20:06:52.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The warrant vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":185992,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000030","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000030/form4.xml","form_type":"4"}},{"id":839730,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-17T20:06:52.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":214563,"derivative":{"exercise_price":6.84,"expiration_date":"2034-05-06","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000030","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000030/form4.xml","form_type":"4"}},{"id":839729,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:06:52.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":641,"price":41.3,"value":26473.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units."}],"balance_after":33377,"source":{"system":"sec-edgar","filing":"0000907654-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000030/form4.xml","form_type":"4"}},{"id":839728,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:06:52.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":1177,"price":41.9361,"value":49358.7897,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.75 to $42.28, inclusive."}],"balance_after":34018,"source":{"system":"sec-edgar","filing":"0000907654-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000030/form4.xml","form_type":"4"}},{"id":839727,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:06:52.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":2902,"price":41.2022,"value":119568.7844,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.72 to $41.70, inclusive."}],"balance_after":35195,"source":{"system":"sec-edgar","filing":"0000907654-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000030/form4.xml","form_type":"4"}},{"id":839726,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:06:52.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":2921,"price":40.1091,"value":117158.6811,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.65 to $40.64, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":38097,"source":{"system":"sec-edgar","filing":"0000907654-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000030/form4.xml","form_type":"4"}},{"id":839725,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:06:52.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":41018,"source":{"system":"sec-edgar","filing":"0000907654-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000030/form4.xml","form_type":"4"}},{"id":839724,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:06:52.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":6.84,"value":23940.0,"ownership":{"direct":true},"balance_after":37518,"source":{"system":"sec-edgar","filing":"0000907654-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000030/form4.xml","form_type":"4"}},{"id":902407,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2026-02-17T22:24:38.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The warrant vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":189492,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000020","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000020/form4.xml","form_type":"4"}},{"id":902406,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-17T22:24:38.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":218063,"derivative":{"exercise_price":6.84,"expiration_date":"2034-05-06","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000020","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000020/form4.xml","form_type":"4"}},{"id":902405,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:24:38.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":936,"price":32.7842,"value":30686.0112,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.69 to $32.93, inclusive."}],"balance_after":34018,"source":{"system":"sec-edgar","filing":"0000907654-26-000020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000020/form4.xml","form_type":"4"}},{"id":902404,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:24:38.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":6064,"price":32.3009,"value":195872.6576,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.68 to $32.67, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full\ninformation regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":34954,"source":{"system":"sec-edgar","filing":"0000907654-26-000020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000020/form4.xml","form_type":"4"}},{"id":902403,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:24:38.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":41018,"source":{"system":"sec-edgar","filing":"0000907654-26-000020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000020/form4.xml","form_type":"4"}},{"id":902402,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-17T22:24:38.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":6.84,"value":23940.0,"ownership":{"direct":true},"balance_after":37518,"source":{"system":"sec-edgar","filing":"0000907654-26-000020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000020/form4.xml","form_type":"4"}},{"id":932717,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-23T22:40:40.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2026."}],"balance_after":130000,"derivative":{"exercise_price":34.39,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000907654-26-000018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000018/form4.xml","form_type":"4"}},{"id":932716,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-23T22:40:40.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The grant vests as to 1/16 of the shares on each March 14, June 14, September 14 and December 14 (or if not a trading day, the immediately preceding trading day)."}],"balance_after":34018,"source":{"system":"sec-edgar","filing":"0000907654-26-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000018/form4.xml","form_type":"4"}},{"id":937752,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2026-01-16T22:26:40.000Z","date":"2026-01-15","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The warrant vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":192992,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000004","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000004/form4.xml","form_type":"4"}},{"id":937751,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-16T22:26:40.000Z","date":"2026-01-15","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":221563,"derivative":{"exercise_price":6.84,"expiration_date":"2034-05-06","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-26-000004","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000004/form4.xml","form_type":"4"}},{"id":937750,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-16T22:26:40.000Z","date":"2026-01-15","kind":"sale","planned":true,"acquired":false,"shares":2619,"price":32.237,"value":84428.703,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.86 to $32.71, inclusive."}],"balance_after":1518,"source":{"system":"sec-edgar","filing":"0000907654-26-000004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000004/form4.xml","form_type":"4"}},{"id":937749,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-16T22:26:40.000Z","date":"2026-01-15","kind":"sale","planned":true,"acquired":false,"shares":4381,"price":31.5626,"value":138275.7506,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.86 to $31.85, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full\ninformation regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":4137,"source":{"system":"sec-edgar","filing":"0000907654-26-000004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000004/form4.xml","form_type":"4"}},{"id":937748,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-16T22:26:40.000Z","date":"2026-01-15","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":8518,"source":{"system":"sec-edgar","filing":"0000907654-26-000004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000004/form4.xml","form_type":"4"}},{"id":937747,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-16T22:26:40.000Z","date":"2026-01-15","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":6.84,"value":23940.0,"ownership":{"direct":true},"balance_after":5018,"source":{"system":"sec-edgar","filing":"0000907654-26-000004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000004/form4.xml","form_type":"4"}},{"id":962554,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2025-12-19T22:38:24.000Z","date":"2025-12-19","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The warrant vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":196492,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-25-000023","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765425000023/form4.xml","form_type":"4"}},{"id":962553,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-19T22:38:24.000Z","date":"2025-12-19","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025."}],"balance_after":225063,"derivative":{"exercise_price":6.84,"expiration_date":"2034-05-06","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000907654-25-000023","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765425000023/form4.xml","form_type":"4"}},{"id":962552,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-19T22:38:24.000Z","date":"2025-12-19","kind":"sale","planned":true,"acquired":false,"shares":3080,"price":31.579,"value":97263.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.21 to $32.00, inclusive."}],"balance_after":1518,"source":{"system":"sec-edgar","filing":"0000907654-25-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765425000023/form4.xml","form_type":"4"}},{"id":962551,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-19T22:38:24.000Z","date":"2025-12-19","kind":"sale","planned":true,"acquired":false,"shares":1492,"price":30.7011,"value":45806.0412,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.20 to $31.18, inclusive."}],"balance_after":4598,"source":{"system":"sec-edgar","filing":"0000907654-25-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765425000023/form4.xml","form_type":"4"}},{"id":962550,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-19T22:38:24.000Z","date":"2025-12-19","kind":"sale","planned":true,"acquired":false,"shares":1787,"price":29.622,"value":52934.514,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.15 to $30.13, inclusive."}],"balance_after":6090,"source":{"system":"sec-edgar","filing":"0000907654-25-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765425000023/form4.xml","form_type":"4"}},{"id":962549,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-19T22:38:24.000Z","date":"2025-12-19","kind":"sale","planned":true,"acquired":false,"shares":641,"price":28.5322,"value":18289.1402,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.14 to $29.12, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full\ninformation regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4), (5) and (6) to this Form 4."}],"balance_after":7877,"source":{"system":"sec-edgar","filing":"0000907654-25-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765425000023/form4.xml","form_type":"4"}},{"id":962548,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-19T22:38:24.000Z","date":"2025-12-19","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":8518,"source":{"system":"sec-edgar","filing":"0000907654-25-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765425000023/form4.xml","form_type":"4"}},{"id":962547,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-19T22:38:24.000Z","date":"2025-12-19","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":6.84,"value":23940.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 191 shares acquired under the Oruka stock purchase plan on December 8, 2024, 661 shares acquired under the Oruka stock purchase plan on June 8, 2025 and 666 shares acquired under the Oruka stock purchase plan on December 8, 2025."}],"balance_after":5018,"source":{"system":"sec-edgar","filing":"0000907654-25-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765425000023/form4.xml","form_type":"4"}},{"id":1295913,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-24T21:43:39.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":162500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2025."}],"balance_after":162500,"derivative":{"exercise_price":12.5,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":162500},"source":{"system":"sec-edgar","filing":"0001062993-25-001088","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000106299325001088/form4.xml","form_type":"4"}},{"id":1544577,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-09T20:22:02.000Z","date":"2024-04-05","kind":"sale","planned":false,"acquired":false,"shares":2753,"price":0.83,"value":2284.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person on March 12, 2020 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."}],"balance_after":53365,"source":{"system":"sec-edgar","filing":"0001415889-24-010570","document":"form4-04092024_080455.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000141588924010570/form4-04092024_080455.xml","form_type":"4"}},{"id":1603302,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-04T21:13:52.000Z","date":"2024-02-29","kind":"sale","planned":false,"acquired":false,"shares":3293,"price":0.89,"value":2930.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person on March 12, 2020 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."}],"balance_after":56118,"source":{"system":"sec-edgar","filing":"0001415889-24-006265","document":"form4-03042024_090307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000141588924006265/form4-03042024_090307.xml","form_type":"4"}},{"id":1649393,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-12T22:13:39.000Z","date":"2023-02-08","kind":"sale","planned":false,"acquired":false,"shares":7770,"price":0.53,"value":4118.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person on March 12, 2020 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."}],"balance_after":59411,"source":{"system":"sec-edgar","filing":"0001415889-24-003400","document":"form4-02122024_100214.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000141588924003400/form4-02122024_100214.xml","form_type":"4"}},{"id":1659002,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-05T21:30:21.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares that vested under a performance-based restricted stock unit award (the \"Award\") granted on March 1, 2023 based on the Issuer's satisfaction of certain performance criteria of the Award. In light of the performance-based vesting conditions of the Award, such shares were not reportable under Section 16 until vesting was determined. On February 1, 2024, the Compensation Committee of the Issuer's Board of Directors certified a 50% level of achievement against the Award's performance goals."}],"balance_after":67181,"source":{"system":"sec-edgar","filing":"0001415889-24-002522","document":"form4-02052024_090202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000141588924002522/form4-02052024_090202.xml","form_type":"4"}},{"id":1843503,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-06-27T20:07:03.000Z","date":"2023-06-23","kind":"sale","planned":true,"acquired":false,"shares":2723,"price":3.51,"value":9557.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person on March 12, 2020 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.45 to $3.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":53681,"source":{"system":"sec-edgar","filing":"0001209191-23-039882","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919123039882/doc4.xml","form_type":"4"}},{"id":1923822,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-04-06T21:13:41.000Z","date":"2023-04-04","kind":"sale","planned":false,"acquired":false,"shares":2481,"price":4.91,"value":12181.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.82 to $4.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":56404,"source":{"system":"sec-edgar","filing":"0001209191-23-023606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919123023606/doc4.xml","form_type":"4"}},{"id":1966165,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-07T21:43:40.000Z","date":"2023-03-03","kind":"sale","acquired":false,"shares":6221,"price":9.71,"value":60405.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.60 to $9.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":58885,"source":{"system":"sec-edgar","filing":"0001209191-23-016788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919123016788/doc4.xml","form_type":"4"}},{"id":1974053,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-03T21:37:03.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on April 1, 2023, in each case subject to the Reporting Person's continued service as of each such date."}],"balance_after":81000,"derivative":{"exercise_price":10.06,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0001209191-23-015566","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919123015566/doc4.xml","form_type":"4"}},{"id":2007838,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-17T21:27:32.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":2265,"price":10.2,"value":23103.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person."}],"balance_after":65106,"source":{"system":"sec-edgar","filing":"0001209191-23-010627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919123010627/doc4.xml","form_type":"4"}},{"id":2050953,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-19T21:18:25.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":2265,"price":10.81,"value":24484.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person."}],"balance_after":67371,"source":{"system":"sec-edgar","filing":"0001209191-23-004013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919123004013/doc4.xml","form_type":"4"}},{"id":2072746,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-03T21:32:27.000Z","date":"2022-12-29","kind":"sale","acquired":false,"shares":2265,"price":10.18,"value":23057.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person."}],"balance_after":69636,"source":{"system":"sec-edgar","filing":"0001209191-23-000232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919123000232/doc4.xml","form_type":"4"}},{"id":2076836,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-23T21:53:37.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":2992,"price":11.27,"value":33719.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on December 21, 2021, and does not represent a discretionary trade by the Reporting Person."}],"balance_after":71901,"source":{"system":"sec-edgar","filing":"0001209191-22-062629","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919122062629/doc4.xml","form_type":"4"}},{"id":2304729,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-04-05T21:50:23.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":1642,"price":11.91,"value":19556.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on April 1, 2021, and does not represent a discretionary trade by the Reporting Person."}],"balance_after":74893,"source":{"system":"sec-edgar","filing":"0001209191-22-023248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919122023248/doc4.xml","form_type":"4"}},{"id":2365666,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-01T21:14:47.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on March 25, 2022, in each case subject to the Reporting Person's continued service as of each such date."}],"balance_after":80000,"derivative":{"exercise_price":10.46,"expiration_date":"2032-02-25","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-22-013983","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919122013983/doc4.xml","form_type":"4"}},{"id":2365665,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-01T21:14:47.000Z","date":"2022-02-25","kind":"sale","acquired":false,"shares":1972,"price":10.29,"value":20291.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of RSUs reported in the Form 4 filed with the Securities and Exchange Commission on August 26, 2021, and does not represent a discretionary trade by the Reporting Person."}],"balance_after":76535,"source":{"system":"sec-edgar","filing":"0001209191-22-013983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919122013983/doc4.xml","form_type":"4"}},{"id":2365664,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-01T21:14:47.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in three equal annual installments on each of February 25, 2023, February 25, 2024 and February 25, 2025, in each case, subject to the Reporting Person's continued service (as that term is defined in the Issuer's 2014 Equity Incentive Plan) as of each such date."}],"balance_after":78507,"source":{"system":"sec-edgar","filing":"0001209191-22-013983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919122013983/doc4.xml","form_type":"4"}},{"id":2462575,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-21T22:29:32.000Z","date":"2021-12-17","kind":"grant","acquired":true,"shares":12607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest as to (i) 50% on December 15, 2022; and (ii) 50% on June 15, 2023, subject to the Reporting Person's continued service with the Issuer through each such vesting date."}],"balance_after":58507,"source":{"system":"sec-edgar","filing":"0001209191-21-070808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919121070808/doc4.xml","form_type":"4"}},{"id":2526489,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-11-03T20:55:02.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":1000,"price":17.15,"value":17150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2021."}],"balance_after":45900,"source":{"system":"sec-edgar","filing":"0001209191-21-062727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919121062727/doc4.xml","form_type":"4"}},{"id":2532838,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-10-28T22:34:46.000Z","date":"2021-10-27","kind":"sale","acquired":false,"shares":1000,"price":15,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2021."}],"balance_after":46900,"source":{"system":"sec-edgar","filing":"0001209191-21-061953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919121061953/doc4.xml","form_type":"4"}},{"id":2583720,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-01T22:06:18.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":2110,"price":14.2,"value":29962.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a \"sell to cover\" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of RSUs reported in the Form 4 filed with the Securities and Exchange Commission on August 26, 2021, and does not represent a discretionary trade by the Reporting Person."}],"balance_after":47900,"source":{"system":"sec-edgar","filing":"0001209191-21-054301","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919121054301/doc4.xml","form_type":"4"}},{"id":2589611,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-26T22:16:21.000Z","date":"2021-08-24","kind":"grant","acquired":true,"shares":6400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares that vested under a performance-based restricted stock unit award (the \"RSU\") based on the Issuer's satisfaction of certain performance criteria of the award. In light of the performance-based vesting conditions of the award, such shares were not reportable under Section 16 until vesting was determined, which occurred on August 24, 2021. The vested shares represents the first of two possible vesting events of the total number of shares subject to the award.  The remaining shares subject to the award will vest only upon the satisfaction of additional performance vesting criteria. Each RSU represents the contingent right to receive one share of common stock of the Issuer."}],"balance_after":50010,"source":{"system":"sec-edgar","filing":"0001209191-21-053536","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919121053536/doc4.xml","form_type":"4"}},{"id":2740961,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":23083,"kind":"person","name":"Goncalves Joana","position":1,"cik":"0001756991","reported_name":"Goncalves Joana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-23T21:05:50.000Z","date":"2021-04-21","kind":"sale","acquired":false,"shares":3000,"price":27.63,"value":82890.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on November 15, 2019 and amended on August 19, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.41 - $28.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":43610,"source":{"system":"sec-edgar","filing":"0001209191-21-028141","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756991/000120919121028141/doc4.xml","form_type":"4"}}],"next_cursor":"2021-04-23T21:05:50.000000Z,2740961"}